Crenolanib, a known a potent inhibitor of PDGFRA and PDGFRB, and avapritinib, a highly selective and potent KIT/PDGFRA inhibitor, have shown promising anti-proliferative activity against D842V mutant GIST (10, 11). Here, KIT is linked to gastrointestinal stromal tumor.